PRVA

SEC source: 0001759655-23-000121 · wk-form4_1685738175.xml · nonDerivative · entry 1

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Brighton Family, LLC

Disclosed balance after: 5,656,693

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.01 to $25.05 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001759655-23-000119 · wk-form4_1685565367.xml · nonDerivative · entry 1

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Brighton Family, LLC

Disclosed balance after: 5,661,746

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.22 to $24.57 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting persons disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001759655-23-000133 · wk-form4_1686949334.xml · derivative · entry 2

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: No plan indicated

Ownership: Indirect · By the Jaya Mehrotra 2021 Trust

Disclosed balance after: 437,481

Underlying: Common Stock · 437,481 shares

Expires 2031-04-29

F1 · kind: On May 15, 2023, the reporting person transferred options to purchase shares of the Issuer's common stock to a trust of which the reporting person is the trustee. The reporting person is the Trustee and his children are beneficiaries.

F2 · derivative.exercise_date: 145,827 of the stock options are fully vested and exercisable. 145,827 of the stock options will vest and become exercisable on April 29, 2024, and 145,827 of the stock options will vest and become exercisable on April 29, 2025.

SEC source: 0001759655-23-000133 · wk-form4_1686949334.xml · derivative · entry 1

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 437,481 shares

Expires 2031-04-29

F1 · kind: On May 15, 2023, the reporting person transferred options to purchase shares of the Issuer's common stock to a trust of which the reporting person is the trustee. The reporting person is the Trustee and his children are beneficiaries.

F2 · derivative.exercise_date: 145,827 of the stock options are fully vested and exercisable. 145,827 of the stock options will vest and become exercisable on April 29, 2024, and 145,827 of the stock options will vest and become exercisable on April 29, 2025.

SEC source: 0001759655-23-000114 · wf-form4_168427219486082.xml · nonDerivative · entry 1

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Brighton Family, LLC

Disclosed balance after: 5,673,861

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.24 to $27.05 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001759655-23-000112 · wf-form4_168418208983726.xml · derivative · entry 3

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 248,830

Underlying: Common Stock · 225 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-23-000112 · wf-form4_168418208983726.xml · nonDerivative · entry 2

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138,457

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022.

SEC source: 0001759655-23-000112 · wf-form4_168418208983726.xml · nonDerivative · entry 1

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138,682

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-23-000104 · wf-form4_168375509510091.xml · nonDerivative · entry 2

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Brighton Family, LLC

Disclosed balance after: 5,692,014

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.02 to $30.12 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001759655-23-000102 · wf-form4_168375488586216.xml · derivative · entry 6

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,784

Underlying: Common Stock · 68 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-23-000102 · wf-form4_168375488586216.xml · nonDerivative · entry 4

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 87,732

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2022.

F3 · price: The price reported in Column 4 is a weighted average price. The shared were sold in multiple transactions at prices ranging from $30.00 to $30.11 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-23-000102 · wf-form4_168375488586216.xml · nonDerivative · entry 3

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 87,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-23-000110 · wf-form4_168383953373743.xml · nonDerivative · entry 1

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,114

F1 · shares: On May 9, 2023, the reporting person received 18,382 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date.

SEC source: 0001759655-23-000108 · wf-form4_168383943861296.xml · nonDerivative · entry 1

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,457

F1 · shares: On May 9, 2023, the reporting person received 73,529 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date.

SEC source: 0001759655-23-000106 · wf-form4_168383924764581.xml · nonDerivative · entry 1

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,538

F1 · shares: On May 9, 2023, the reporting person received 22,058 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date.

SEC source: 0001209191-23-028501 · doc4.xml · nonDerivative · entry 1

MBD Advisors, L.L.C. · CIK 0001589295 · 10% owner

MBD 2013, L.P. · CIK 0001572501 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 110,337

F1 · price: Pursuant to an underwriting agreement, dated May 4, 2023 (the "Underwriting Agreement"), Broad Street, MBD Holdings and Bridge Street Holdings offered and sold an aggregate 24,819,473 shares of Common Stock as set forth in the final prospectus filed by the Issuer on May 5, 2023, which offering was consummated on May 8, 2023 (the "Offering"). The amount above represents the $22.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $0.385 per share of Common Stock.

F1 · ownership.direct: Pursuant to an underwriting agreement, dated May 4, 2023 (the "Underwriting Agreement"), Broad Street, MBD Holdings and Bridge Street Holdings offered and sold an aggregate 24,819,473 shares of Common Stock as set forth in the final prospectus filed by the Issuer on May 5, 2023, which offering was consummated on May 8, 2023 (the "Offering"). The amount above represents the $22.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $0.385 per share of Common Stock.

F2 · ownership.direct: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman Sachs & Co. LLC ("Goldman Sachs"), MBD 2013, L.P. ("MBD Onshore"), MBD 2013 Offshore, L.P. ("MBD Offshore"), MBD 2013 Holdings, L.P. ("MBD Holdings"), Broad Street Principal Investments, L.L.C. ("Broad Street"), Bridge Street 2013, L.P. ("Bridge Street Onshore"), Bridge Street 2013 Offshore, L.P. ("Bridge Street Offshore"), Bridge Street 2013 Holdings, L.P. ("Bridge Street Holdings" and, together with MBD Onshore, MBD Offshore, MBD Holdings, Broad Street, Bridge Street Onshore and Bridge Street Offshore, the "GS Funds"), MBD Advisors, L.L.C. ("MBD Advisors"), and Bridge Street Opportunity Advisors, L.L.C. ("Bridge Street Advisors" and, together with GS Group, Goldman Sachs, the GS Funds and MBD Advisors, the "Reporting Persons").

F3 · ownership.direct: Because of the relationships among the Reporting Persons, each of GS Group and Goldman Sachs may be deemed a beneficial owner of all such shares of Common Stock, MBD Advisors, MBD Onshore and MBD Offshore may be deemed a beneficial owner of the shares held by MBD 2013 Holdings and Bridge Street Advisors, Bridge Street Onshore and Bridge Street Offshore may be deemed a beneficial owner of the shares held by Bridge Street Holdings. Affiliates of Goldman Sachs and GS Group are the general partner, managing general partner, managing partner, managing member or member of the GS Funds. Each of Goldman Sachs and Broad Street is a subsidiary of GS Group. Goldman Sachs is the investment manager of certain of the GS Funds.

F4 · ownership.direct: The Reporting Persons disclaim beneficial ownership of all shares of Common Stock except to the extent of their pecuniary interest therein, if any, and this report shall not be deemed an admission that any such person or entity is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F5 · ownership.direct: Due to the electronic system's limitation of 10 Reporting Persons per joint filing, this statement is being filed in duplicate.

SEC source: 0001759655-23-000104 · wf-form4_168375509510091.xml · nonDerivative · entry 1

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Brighton Family, LLC

Disclosed balance after: 5,693,314

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.01 to $30.02 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001759655-23-000102 · wf-form4_168375488586216.xml · derivative · entry 5

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,852

Underlying: Common Stock · 5,376 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-23-000102 · wf-form4_168375488586216.xml · nonDerivative · entry 2

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 87,732

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shared were sold in multiple transactions at prices ranging from $30.00 to $30.06 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-23-000102 · wf-form4_168375488586216.xml · nonDerivative · entry 1

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 93,108

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-23-028495 · doc4.xml · nonDerivative · entry 1

BERNSTEIN JEFFREY DANIEL · CIK 0001859499 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 110,337

F1 · price: Pursuant to an underwriting agreement, dated May 4, 2023 (the "Underwriting Agreement"), Broad Street Principal Investments, L.L.C., MBD 2013 Holdings L.P. and Bridge Street 2013 Holdings L.P. offered and sold an aggregate 24,819,473 shares of Common Stock as set forth in the final prospectus filed by the Issuer on May 5, 2023, which offering was consummated on May 8, 2023 (the "Offering"). The amount above represents the $22.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $0.385 per share of Common Stock.

F1 · ownership.direct: Pursuant to an underwriting agreement, dated May 4, 2023 (the "Underwriting Agreement"), Broad Street Principal Investments, L.L.C., MBD 2013 Holdings L.P. and Bridge Street 2013 Holdings L.P. offered and sold an aggregate 24,819,473 shares of Common Stock as set forth in the final prospectus filed by the Issuer on May 5, 2023, which offering was consummated on May 8, 2023 (the "Offering"). The amount above represents the $22.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $0.385 per share of Common Stock.

F2 · ownership.direct: The Reporting Person is a managing director of Goldman Sachs & Co. LLC ("Goldman Sachs"). Goldman Sachs is a subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any.

SEC source: 0001493152-23-016378 · ownership.xml · nonDerivative · entry 1

Pamplona Capital Partners III, L.P. · CIK 0001554914 · 10% owner

Pamplona Equity Advisors III Ltd · CIK 0001859731 · 10% owner

Pamplona Private Equity Carryco III, L.P. · CIK 0001915347 · 10% owner

Pamplona Equity Carryco Advisors III, Ltd. · CIK 0001915350 · 10% owner

Pamplona PE Investments II, Ltd. · CIK 0001915345 · 10% owner

Pamplona PE Investments Malta Ltd · CIK 0001650903 · 10% owner

Pamplona Capital Management, LLP · CIK 0001554942 · 10% owner

Pamplona Capital Management, LLC · CIK 0001554913 · 10% owner

Halsted John C. · CIK 0001844403 · 10% owner

Knaster Alexander M · CIK 0001308574 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

F2 · shares: Pursuant to an underwriting agreement, dated May 4, 2023 (the "Underwriting Agreement"), and in connection with a registered secondary offering and sale of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. (the "Company") by the selling stockholders listed on Schedule I to the Underwriting Agreement, PCP III sold 13,483,709 shares of Common Stock and Carryco III sold 4,258,014 shares of Common Stock at a purchase price of $21.615 per share.

F2 · price: Pursuant to an underwriting agreement, dated May 4, 2023 (the "Underwriting Agreement"), and in connection with a registered secondary offering and sale of common stock, par value $0.01 per share (the "Common Stock") of Privia Health Group, Inc. (the "Company") by the selling stockholders listed on Schedule I to the Underwriting Agreement, PCP III sold 13,483,709 shares of Common Stock and Carryco III sold 4,258,014 shares of Common Stock at a purchase price of $21.615 per share.

F1 · ownership.nature: This statement is being filed by (i) Pamplona Capital Partners III, L.P. ("PCP III") (ii) Pamplona Equity Advisors III Ltd. ("PEA III"), (iii) Pamplona Private Equity Carryco III, L.P. ("Carryco III"), (iv) Pamplona Equity Carryco Advisors III, Ltd. ("PECA III"), (v) Pamplona PE Investments II, Ltd. ("PE Inv II"), (vi) Pamplona PE Investments Malta Limited ("PE Malta"), (vii) Pamplona Capital Management LLP, (viii) Pamplona Capital Management LLC, (ix) John C. Halsted and (x) Alexander M. Knaster (the foregoing, collectively, the "Reporting Persons").

F3 · ownership.nature: PCP III and Carryco III are controlled by their respective general partners, PEA III and PECA III, which are both owned by PE Inv II, itself owned 100% by Mr. Knaster. PE Malta serves as an investment manager to PCP III. Pamplona Capital Management LLP and Pamplona Capital Management LLC (collectively, the "Pamplona Manager Entities") serve as investment advisors to PE Malta. Messrs. Halsted and Knaster are the principals of the Pamplona Manager Entities. Accordingly, each Reporting Person may be deemed to share beneficial ownership of the securities held of record by PCP III and Carryco III.

F4 · ownership.nature: Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such person or entity is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

SEC source: 0001209191-23-028499 · doc4.xml · nonDerivative · entry 1

GOLDMAN SACHS GROUP INC · CIK 0000886982 · 10% owner

GOLDMAN SACHS & CO. LLC · CIK 0000769993 · 10% owner

Bridge Street 2013 Holdings, L.P. · CIK 0001615711 · 10% owner

Bridge Street 2013 Offshore, L.P. · CIK 0001572491 · 10% owner

Bridge Street 2013, L.P. · CIK 0001572490 · 10% owner

Bridge Street Opportunity Advisors, L.L.C. · CIK 0001615636 · 10% owner

MBD 2013 Holdings, L.P. · CIK 0001615732 · 10% owner

MBD 2013 Offshore, L.P. · CIK 0001572502 · 10% owner

Broad Street Principal Investments, L.L.C. · CIK 0001575993 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 110,337

F1 · price: Pursuant to an underwriting agreement, dated May 4, 2023 (the "Underwriting Agreement"), Broad Street, MBD Holdings and Bridge Street Holdings offered and sold an aggregate 24,819,473 shares of Common Stock as set forth in the final prospectus filed by the Issuer on May 5, 2023, which offering was consummated on May 8, 2023 (the "Offering"). The amount above represents the $22.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $0.385 per share of Common Stock.

F1 · ownership.direct: Pursuant to an underwriting agreement, dated May 4, 2023 (the "Underwriting Agreement"), Broad Street, MBD Holdings and Bridge Street Holdings offered and sold an aggregate 24,819,473 shares of Common Stock as set forth in the final prospectus filed by the Issuer on May 5, 2023, which offering was consummated on May 8, 2023 (the "Offering"). The amount above represents the $22.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $0.385 per share of Common Stock.

F2 · ownership.direct: This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group"), Goldman Sachs & Co. LLC ("Goldman Sachs"), MBD 2013, L.P. ("MBD Onshore"), MBD 2013 Offshore, L.P. ("MBD Offshore"), MBD 2013 Holdings, L.P. ("MBD Holdings"), Broad Street Principal Investments, L.L.C. ("Broad Street"), Bridge Street 2013, L.P. ("Bridge Street Onshore"), Bridge Street 2013 Offshore, L.P. ("Bridge Street Offshore"), Bridge Street 2013 Holdings, L.P. ("Bridge Street Holdings" and, together with MBD Onshore, MBD Offshore, MBD Holdings, Broad Street, Bridge Street Onshore and Bridge Street Offshore, the "GS Funds"), MBD Advisors, L.L.C. ("MBD Advisors"), and Bridge Street Opportunity Advisors, L.L.C. ("Bridge Street Advisors" and, together with GS Group, Goldman Sachs, the GS Funds and MBD Advisors, the "Reporting Persons").

F3 · ownership.direct: Because of the relationships among the Reporting Persons, each of GS Group and Goldman Sachs may be deemed a beneficial owner of all such shares of Common Stock, MBD Advisors, MBD Onshore and MBD Offshore may be deemed a beneficial owner of the shares held by MBD 2013 Holdings and Bridge Street Advisors, Bridge Street Onshore and Bridge Street Offshore may be deemed a beneficial owner of the shares held by Bridge Street Holdings. Affiliates of Goldman Sachs and GS Group are the general partner, managing general partner, managing partner, managing member or member of the GS Funds. Each of Goldman Sachs and Broad Street is a subsidiary of GS Group. Goldman Sachs is the investment manager of certain of the GS Funds.

F4 · ownership.direct: The Reporting Persons disclaim beneficial ownership of all shares of Common Stock except to the extent of their pecuniary interest therein, if any, and this report shall not be deemed an admission that any such person or entity is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F5 · ownership.direct: Due to the electronic system's limitation of 10 Reporting Persons per joint filing, this statement is being filed in duplicate.

SEC source: 0001759655-23-000099 · wf-form4_168366684703758.xml · derivative · entry 5

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 249,055

Underlying: Common Stock · 24,504 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-23-000099 · wf-form4_168366684703758.xml · derivative · entry 4

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 113,066

Underlying: Common Stock · 75,496 shares

Expires 2034-12-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-23-000099 · wf-form4_168366684703758.xml · nonDerivative · entry 3

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,928

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022.

F3 · price: The price reported in Column 4 is a weighted average price. The shared were sold in multiple transactions at prices ranging from $29.00 to $29.12 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-23-000099 · wf-form4_168366684703758.xml · nonDerivative · entry 2

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,652

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-23-000099 · wf-form4_168366684703758.xml · nonDerivative · entry 1

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 182,229

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-23-000096 · wf-form4_168331865690092.xml · derivative · entry 3

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 131,228

Underlying: Common Stock · 15,000 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-23-000096 · wf-form4_168331865690092.xml · nonDerivative · entry 2

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 87,732

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.95 to $27.87 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-23-000096 · wf-form4_168331865690092.xml · nonDerivative · entry 1

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-23-000088 · wf-form4_168315337493414.xml · nonDerivative · entry 4

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,645

F5 · shares: The sale of 8,094 shares reported in this row represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to a "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold as part of a trade on behalf of multiple employees of Privia Health Group, Inc. in multiple transactions at prices ranging from $26.95 to $27.87 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-23-000089 · wf-form4_168315345909075.xml · nonDerivative · entry 4

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 82,229

F5 · shares: The sale of 7,625 shares reported in this row represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to a "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold as part of a trade on behalf of multiple employees of Privia Health Group, Inc. in multiple transactions at prices ranging from $26.95 to $27.87 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-23-000087 · wf-form4_168315327551032.xml · nonDerivative · entry 2

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,732

F1 · kind: These sales represent nondiscretionary sales of shares required to be sold by the reporting person pursuant to "sell to cover" transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold as part of a trade on behalf of multiple employees of Privia Health Group, Inc. in multiple transactions at prices ranging from $26.95 to $27.87 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-23-000086 · wf-form4_168315321965663.xml · nonDerivative · entry 2

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,480

F1 · kind: These sales represent nondiscretionary sales of shares required to be sold by the reporting person pursuant to "sell to cover" transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold as part of a trade on behalf of multiple employees of Privia Health Group, Inc. in multiple transactions at prices ranging from $26.95 to $27.87 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-23-000088 · wf-form4_168315337493414.xml · derivative · entry 5

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,381,766

Underlying: Common Stock · 17,185 shares

Expires 2033-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-23-000088 · wf-form4_168315337493414.xml · nonDerivative · entry 3

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 113,739

F3 · shares: The sale of 8,000 shares reported in this row represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to a "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold as part of a trade on behalf of multiple employees of Privia Health Group, Inc. in multiple transactions at prices ranging from $27.29 to $27.92 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-23-000088 · wf-form4_168315337493414.xml · nonDerivative · entry 2

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,739

F1 · shares: The sale of 17,185 shares reported in this row were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.16 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-23-000088 · wf-form4_168315337493414.xml · nonDerivative · entry 1

Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138,924

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-23-000089 · wf-form4_168315345909075.xml · derivative · entry 6

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 188,562

Underlying: Common Stock · 9,087 shares

Expires 2034-12-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-23-000089 · wf-form4_168315345909075.xml · derivative · entry 5

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,739

Underlying: Common Stock · 11,699 shares

Expires 2035-09-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-23-000089 · wf-form4_168315345909075.xml · nonDerivative · entry 3

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,854

F3 · shares: The sale of 7,537 shares reported in this row represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to a "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold as part of a trade on behalf of multiple employees of Privia Health Group, Inc. in multiple transactions at prices ranging from $27.29 to $27.92 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-23-000089 · wf-form4_168315345909075.xml · nonDerivative · entry 2

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 97,391

F1 · shares: The sale of 20,786 shares reported in this row were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.16 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-23-000089 · wf-form4_168315345909075.xml · nonDerivative · entry 1

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,177

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001759655-23-000087 · wf-form4_168315327551032.xml · nonDerivative · entry 1

Bartrum Thomas · CIK 0001859681 · EVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,554

F1 · kind: These sales represent nondiscretionary sales of shares required to be sold by the reporting person pursuant to "sell to cover" transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold as part of a trade on behalf of multiple employees of Privia Health Group, Inc. in multiple transactions at prices ranging from $27.29 to $27.92 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-23-000086 · wf-form4_168315321965663.xml · nonDerivative · entry 1

Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,220

F1 · kind: These sales represent nondiscretionary sales of shares required to be sold by the reporting person pursuant to "sell to cover" transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold as part of a trade on behalf of multiple employees of Privia Health Group, Inc. in multiple transactions at prices ranging from $27.29 to $27.92 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001759655-23-000094 · wf-form4_168323281895595.xml · nonDerivative · entry 2

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Brighton Family, LLC

Disclosed balance after: 5,699,859

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.46 to $27.80 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001759655-23-000094 · wf-form4_168323281895595.xml · nonDerivative · entry 1

Sullivan William M · CIK 0001859839 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Brighton Family, LLC

Disclosed balance after: 5,709,560

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shared were sold in multiple transactions at prices ranging from $26.46 to $27.45 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3 · ownership.nature: Represents shares of common stock owned by Brighton Family, LLC. The reporting person is the managing member of Brighton Family, LLC and has sole voting and investment power with respect to the common stock owned by Brighton Family, LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001759655-23-000076 · wf-form4_168297876896719.xml · derivative · entry 3

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,438

Underlying: Common Stock · 1,102 shares

Expires 2035-09-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: All stock options are fully vested and exercisable.

SEC source: 0001759655-23-000076 · wf-form4_168297876896719.xml · nonDerivative · entry 2

Mehrotra Parth · CIK 0001858398 · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 97,391

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022.